This activated phenotype is mediated through multiple factors within the TME, mainly transforming growth factor β (TGF-β), but also fibroblast growth factor 2 (FGF-2) and platelet-derived growth factor (PDGF), paracrine factors secreted mostly by tumour cells [83]. This evidence concerns the gene FGF2 and neoplasm.